Methyl 3,5,6-trimethylpyrazine-2-carboxylate

Catalog No.: 
ACAZEO794
CAS No.: 
1332730-39-8
Molecular Formula: 
C9H12N2O2
Molecular Weight: 
180.21
Methyl 3,5,6-trimethylpyrazine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$242.00InquiryInquiry
250mg97%$432.00InquiryInquiry
1g97%$1068.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3,5,6-trimethylpyrazine-2-carboxylate
IUPAC Namemethyl 3,5,6-trimethylpyrazine-2-carboxylate
MDL No.MFCD28363946
Molecular FormulaC9H12N2O2
Molecular Weight180.21
SMILESO=C(C1=NC(C)=C(C)N=C1C)OC
InChI KeyKKAPAZGSBHLPDS-UHFFFAOYSA-N
SynonymMethyl 3,5,6-trimethylpyrazine-2-carboxylate;2-Pyrazinecarboxylic acid, 3,5,6-trimethyl-, methyl ester
CAS No.1332730-39-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P301+P312-P330

Synthetic Route by SureRoute

1. ACAZEO794 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAZEO794 route product structure diagram
    ACAZEO7941332730-39-8
Inquiry

2. ACAZEO794 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCWDA697 route compound structure diagram
    ACCWDA69713061-96-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAZEO794 route product structure diagram
    ACAZEO7941332730-39-8
Inquiry

3. ACAZEO794 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAZEO794 route product structure diagram
    ACAZEO7941332730-39-8
Inquiry

Comments (0)